ER、PR、HER-2和 Ki67在乳腺髓样癌中的表达及其临床意义
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Expressions and clinical significances of ER,PR,HER-2 and Ki67 in human medullary carcinoma of the breast
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨乳腺髓样癌(Medullary carcinoma of the breast,MBC)的雌激素受体(Estrogen receptor,ER)、孕激素受体(Progesterone receptor,PR)、人表皮生长因子受体-2(Human epidermal growth factor receptor-2,HER-2)和细胞增殖抗原Ki67表达情况及其临床意义。方法:收集43例临床病理资料完整的MBC病例,采用免疫组化S-P法检测癌组织中ER、PR、HER-2、Ki67 的表达情况并分析其结果,取同期的120例乳腺浸润性导管癌(Invasive ductal carcinoma,IDC)作对照研究。结果:免疫组化显示MBC组ER阳性率为8/43(18.75%),PR阳性率为11/43(25.58%),Her-2阳性率为14/43 (32.56%),Ki67阳性率为7/43(16.28%)。乳腺IDC中ER、PR、HER-2、Ki67的阳性率分别为25/120(20.83%)、33/120(27.50%)、49/120(40.83%)、42/120(35.00%)。Ki67的阳性率明显高于MBC组,差异有统计学意义(P<0.05)。Ki67的表达与患者的年龄、临床分期无显著相关性,而与肿瘤大小以及有无淋巴结转移有关(P<0.05)。MBC组织中Ki67表达强度与Her-2呈正相关性(r=0.447,P<0.05);与ER和PR的表达无显著相关性(r=0.113和r=1.129,P >0.05)。结论:Ki67表达与乳腺癌发生、发展有关,可作为评价MBC发生、发展的生物学指标,联合ER、PR、HER-2检测有助于MBC预后的判断。

    Abstract:

    Objective:To investigate the expressions and clinical significances of estrogen receptor(ER),progesterone receptor(PR),human epidermal growth factor receptor-2(HER-2) and cell proliferative nuclear antigen Ki67 in human medullary carcinoma of the breast. Methods:The pathological data of 43 cases of medullary breast carcinoma(MBC) were collected. The expressions of ER,PR,HER-2 and Ki67 in carcinoma tissues in 43 cases were detected by immunohistochemical S-P method. Another 120 cases of invasive ductal carcinoma(IDC) of the breast were chosen as the controls. Results:The positive expression rates of ER,PR,HER-2 and Ki67 in MBC tissues were 8/43(18.75%),11/43(25.58%),14/43(32.56%),7/43(16.28%),respectively;meanwhile,the positive rates in IDC were 25/120(20.83%),33/120(27.50%),49/120 (40.83%),42/120(35.00%),respectively. The positive rate of Ki67 in IDC was significantly higher than that in MBC(P<0.05). The positive expression of Ki67 was associated with tumor volume and lymph node metastasis(P<0.05),but not correlated with the age and clinical stage. There was a positive relationship between the expression of Ki67 and HER-2(r=0.447,P<0.05) and there was no relationship between the expression of Ki67 and PR and PR(r=0.113 and r=1.129,P >0.05). Conclusions:The expression of Ki67 is correlated with the genesis,development of breast cancer,which can be con-sidered as a biological indicator in MBC. It will be useful for the prognosis through detecting the expression of Ki67 combined with ER,PR and HER-2.

    参考文献
    相似文献
    引证文献
引用本文

高敏娜,李 昱. ER、PR、HER-2和 Ki67在乳腺髓样癌中的表达及其临床意义[J].重庆医科大学学报,2012,37(9):779-782

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2012-09-17
  • 出版日期:
文章二维码